What guidance did 22nd Century's management provide for the next earnings period?

What does 22nd Century do and what are its main business segments?

What factors drove the changes in 22nd Century's revenue and profit?

What were the key takeaways from 22nd Century's earnings call?

What were the key takeaways from 22nd Century’s earnings call?

What is 22nd Century's gross profit margin?

What is the market's earnings forecast for 22nd Century next quarter?

What is 22nd Century's latest dividend and current dividend yield?

- **Strategic Shift to VLN**: Transitioned to high-margin VLN cigarettes, with 6,000 cartons shipped and 1,500 store distribution across 21 states.
- **Financial Turnaround**: Debt-free with $14 million cash, improved balance sheet (2.3:1 current ratio), and Q3 2025 revenue of $4 million.
- **Partnerships & Expansion**: Co-branded VLN products with retailers, FDA-authorized 100mm VLN cigarettes, and low-nicotine cigars for 2026 mandate readiness.
- **Growth Outlook**: Target Q2 2026 EBITDA breakeven, supported by $25 million ATM facility and licensing opportunities.

**【CEO Summary Section】**
- Transitioned from restructuring to growth phase, achieving debt-free status with $14 million in cash.
- Focused on Very Low Nicotine (VLN) combustible cigarettes, with 6,000 cartons shipped of branded and partner-branded VLN products.
- Expanded distribution to 1,500 stores across 21 states, targeting 500,000 carton breakeven point for higher-margin products.
- Launched new natural style cigarettes (e.g., SmokerFriendly Black Label) to complement VLN offerings and improve profitability.
- Filed PMTA for 100mm VLN cigarettes and developed low-nicotine filtered cigars, positioning for FDA's 2026 low nicotine mandate.
- Partnered with retailers (e.g., Murphy USA, Circle K) to co-brand VLN products, leveraging existing infrastructure for rapid market penetration.

**【CFO Financial Commentary】**
- Q3 2025: $4 million revenue (down 2.4% QoQ) with 517,000 cartons sold, reflecting strategic shift away from low-margin CMO business.
- Gross loss of $1.1 million (vs. $0.6 million Q2) due to transition costs and inventory write-downs.
- Operating expenses stable at $2.2 million, with interest expense reduced to $0.5 million post-debt repayment.
- Adjusted EBITDA loss of $2.9 million (vs. $2.6 million Q2), driven by restructuring and lower volume.
- Balance sheet improved to $32.4 million in assets (including $9.5 million insurance recovery) with no debt and 2.3:1 current ratio.

**【Q&A Highlights】**
- **Cash Utilization**: $14 million will fund VLN distribution expansion, R&D, and CapEx for 2026 growth.
- **Warrants**: No plans to settle outstanding warrants; fully diluted shares at 23.7 million.
- **Severance & Sales Agreements**: Executive agreements formalize terms without impacting SG&A; at-the-market (ATM) facility provides $25 million growth capital flexibility.
- **Breakeven Target**: Maintain Q2 2026 EBITDA breakeven goal, contingent on VLN adoption rates and marketing effectiveness.
- **Licensing Strategy**: Open to licensing VLN technology to peers, positioning for FDA mandate compliance and market leadership.

22nd Century Group, Inc. (XXII) Q3 2025 Earnings Call Transcript

- **FDA-Compliant VLN Launch**: Pinnacle VLN and Smoker-Friendly VLN products launched in August 2025, targeting 11.5 million U.S. smokers to reduce nicotine dependence.
- **Margin Shift Strategy**: Transitioning from low-margin CMO exports to high-margin branded VLN products, delaying breakeven to Q1/Q2 2026.
- **Financial Challenges**: Q2 2025 revenue down 33% YoY to $4 million, with EBITDA loss of $2.6 million, but debt reduced by $1 million.
- **Key Risk**: Breakeven timeline hinges on branded product adoption rates, with potential need for additional funding.

**【CEO Summary Section】**
- 22nd Century is positioned as a leader in tobacco harm reduction with its 95% low nicotine VLN cigarettes, compliant with the FDA's proposed low nicotine mandate.
- Launched Pinnacle VLN and Smoker-Friendly VLN products in August 2025, with a major retailer soft launch in early September and full launch in October.
- Shifting focus to higher-margin branded products (VLN and Partner VLN) to improve gross margins, despite near-term revenue decline from exiting low-margin CMO business.
- Emphasized the competitive advantage of VLN cigarettes over heat-not-burn devices, as they require no battery operation and maintain traditional smoking habits.
- Projected 11.5 million U.S. smokers could reduce nicotine dependence through VLN adoption, based on a 2024 study showing 40% reduction in smoking frequency among 450 subjects.

**【CFO Financial Commentary】**
- Q2 2025 net revenue: $4 million (down from $6 million in Q1 2025) due to higher volume of low-margin CMO exports.
- Gross margin loss: $0.6 million (consistent with Q1 2025).
- Operating expenses: $2.3 million (up from $2 million in Q1 2025), but sustainable as branded product launches begin.
- Adjusted EBITDA loss: $2.6 million (worsened from $2.3 million in Q1 2025).
- Debt reduced by $1 million, with remaining debt set to roll over in March 2026.
- Breakeven on EBITDA now expected in Q1 or Q2 2026, delayed due to slower-than-anticipated branded product adoption.

**【Q&A Key Highlights】**
- **Breakeven Timeline**: CFO Dan Otto confirmed breakeven on EBITDA will occur in Q1 or Q2 2026, depending on branded product sales rates and store penetration.
- **Cash Sufficiency**: CEO Larry Firestone stated current $3 million cash balance may require additional funding, but future raises will be smaller-scale to avoid dilution.
- **Debt Management**: Company in discussions to extinguish debt alongside potential equity raises.
- **MRTP Renewal**: CEO expressed confidence VLN products will be renewed under FDA's Modified Risk Tobacco Product (MRTP) framework, given alignment with FDA's low nicotine mandate.


22nd Century Group, Inc. (XXII) Q2 2025 Earnings Call Transcript

- **Revenue Recovery**: Q1 2025 revenue up 50% to $6M, driven by CMO contract repricing and expanding branded product distribution.
- **VLN Growth Catalyst**: FDA-approved VLN products gaining state approvals, with potential to create a new retail category separate from standard cigarettes.
- **Breakeven in Sight**: CFO targets Q4 2025 EBITDA breakeven, supported by 41% sequential volume growth and improving gross margins.
- **Financial Health**: Debt reduced 52% YoY to $3.9M, operating expenses at lowest level since turnaround, and $5.4M cash infusion from warrant exercises.
- **Market Opportunity**: Big tobacco's price hikes and nicotine innovation are accelerating consumer shift to Tier 4, directly benefiting Smoker Friendly and Pinnacle.


**【CEO Summary Section】**
- **Market Dynamics**: The $85B combustible cigarette market is facing price pressures and nicotine delivery innovation from big tobacco, creating opportunities for 22nd Century's value-focused (Tier 4) and low-nicotine (VLN) products.
- **Product Portfolio**: Key brands include Smoker Friendly (natural cigarettes at competitive pricing), Pinnacle (value-focused SKUs), and VLN (FDA-approved low-nicotine cigarettes). New product launches include Smoker Friendly Black Label and expanded VLN SKUs across CMO partners.
- **Growth Strategy**: Expanding state approvals for VLN and branded products, with a focus on same-store sales growth and new distribution channels. Targeting a VLN category separation in retail to differentiate from standard cigarettes.
- **Operational Momentum**: Sequential volume growth of 41% (476K cartons Q1 vs. 338K Q4) driven by repriced CMO contracts and expanding branded product distribution.

**【CFO Financial Commentary】**
- **Revenue & Margin**: Q1 2025 revenue $6M (+50% vs. Q4 2024), gross loss $0.6M (50% improvement). Sequential volume growth reflects stabilization of CMO contracts post-last-time buys.
- **Cost Control**: Operating expenses $2M (lowest since turnaround), net loss $3.3M (vs. $4.2M prior quarter). Adjusted EBITDA loss $2.3M (vs. $3.9M prior quarter).
- **Balance Sheet**: Debt reduced to $3.9M (down $4.1M YoY), cash runway extended with $5.4M warrant exercise and $3.3M option. Accounts receivable increase due to new contract assets.
- **Liquidity**: $2.9M cash used in operations, with focus on minimizing cash burn while executing growth.

**【Q&A Highlights】**
- **Breakeven Timeline**: CFO reaffirms Q4 2025 EBITDA breakeven target, driven by CMO volume recovery and VLN distribution expansion.
- **Warrant Exercise**: 7M shares issued in Q1, with another 4M potential from remaining warrants. Prioritizing P&L and balance sheet over capital table optimization.
- **Competitor Impact**: Big tobacco's price hikes and nicotine delivery innovation are driving consumer migration to Tier 4, benefiting Smoker Friendly and Pinnacle. VLN positioned to capture health-conscious smokers regardless of FDA rule timing.
- **AR Management**: Receivables collected upon shipment, with no material timing risk beyond normal trade terms.


22nd Century (XXII)-13 May 25-2025 Q1 Earnings call transcript

- **VLN Market Leadership**: Only FDA-compliant product for FDA's proposed 0.7 mg/g nicotine standard; partner VLN under Smoker Friendly to expand reach. 
- **CMO Recovery**: Filtered cigar volume down 23% YoY in Q4 2024, but Q1 2025+ growth expected from repriced contracts. 
- **2025 Financial Targets**: EBITDA breakeven by Q4, debt reduced to $4.6 million, and VLN driving margin expansion. 
- **FDA Tailwind**: Potential 2027 implementation of nicotine standard could monopolize VLN as compliant product.

**【CEO Summary Section】**
- **Turnaround Progress**: Reduced total liabilities by $18 million in 2024, restructured contracts with CMO customers to improve margins, and relaunched VLN with new packaging and marketing. 
- **VLN Strategy**: Introducing 3 SKUs of VLN (gold, red, green/menthol) and partner VLN under other brands (e.g., Smoker Friendly VLN) to expand market presence. Targeting FDA's proposed nicotine yield standard (0.7 mg/g) with VLN as the only compliant product. 
- **CMO Business**: Filtered cigar volume dipped in Q4 2024 due to contract repricing, but Q1 2025+ volumes expected to recover as new contracts take effect. Smoker Friendly's Black cigarette launch is a growth driver. 
- **2025 Outlook**: Focus on VLN distribution expansion, achieving breakeven EBITDA by Q4 2025, and reducing debt to $4.6 million. 

**【CFO Financial Commentary】**
- **Q4 2024 Results**: Net revenue $4 million (down 31% YoY), gross loss $1.2 million, operating expenses $2.8 million (flat QoQ). 
- **Balance Sheet Improvement**: Total liabilities reduced to $17.7 million (down 49% YoY), positive working capital $1.6 million (vs. -$8.8 million prior). 
- **Cash Flow**: Reduced cash interest by 44% YoY to $722,000; $3.1 million debt repayment in Q1 2025 brings principal to $4.6 million. 
- **2025 Targets**: Revenue growth from CMO contracts and VLN launches, EBITDA breakeven by Q4. 

**【Q&A Highlights】**
- **CMO Contract Stability**: Contract adjustments completed in 2024; Q1 2025+ volumes to recover. 
- **Breakeven Confidence**: Maintain Q4 2025 EBITDA breakeven target despite near-term challenges. 
- **Legal Update**: Lawsuit against Dorchester Insurance for $9 million claim set for trial in November 2025.

22nd Century (XXII)-20 Mar 25-2024 Q4 Earnings call transcript

22nd Century (XXII)-12 Nov 24-2024 Q3 Earnings call transcript

22nd Century (XXII)-13 Aug 24-2024 Q2 Earnings call transcript

22nd Century (XXII)-15 May 24-2024 Q1 Earnings call transcript

- **Strategic Restructuring**: Divested cannabis business, reduced workforce to 60, and cut costs to focus on VLN and CMO. 
- **Financial Improvement**: Adjusted EBITDA loss narrowed to $3.2M in Q4, down from $9.9M prior year. 
- **Breakeven Target**: Aiming for cash neutrality by Q1 2025 via CMO growth and VLN sales. 
- **Legal Action**: Pursuing $9M+ insurance recovery for 2020 fire damage. 
- **Share Restructuring**: 1:16 reverse split to regain NASDAQ compliance.

**【Management Opening Remarks】**
- CEO Larry Firestone emphasized the company's pivot to focus solely on its core tobacco business, particularly the VLN (Very Low Nicotine) brand, after divesting its cannabis operations (GBB) in December 2023. 
- The company has reduced its workforce to 60 employees, eliminated bonuses and equity compensation for executives, and cut Board compensation. 
- A reverse stock split of 1:16 will take effect on April 2, 2024, to regain NASDAQ compliance.

**【CEO Commentary】**
- Sold GBB to reduce cash burn and eliminate cannabis-related cost premiums, freeing up $1.2M from selling excess inventory. 
- VLN strategy: Pricing filtered cigars to profitability or exiting unprofitable lines; CMO (Contract Manufacturing) opportunities for additional revenue. 
- Targeting breakeven by Q1 2025 through cost reductions and new CMO contracts. 
- VLN sales velocity slow but improving; plans to enhance digital and retail presence with limited budget. 

**【CFO Financial Commentary】**
- Q4 2023: Net sales $7.4M (-26% YoY), gross loss $7.8M due to inventory reserves. 
- Adjusted EBITDA loss $3.2M (vs. $9.9M prior year), cash $2M. 
- Lawsuit against insurer for $9M+ from 2020 fire; court hearing in April. 

**【Q&A Highlights】**
- VLN marketing: Limited budget for digital, retail displays, and FDA-compliant materials. 
- CMO pipeline: 6 new opportunities to increase production volume and lower per-unit costs. 
- GBB refinancing: Counterparty progressing on $10M loan; 22nd Century may receive $1.2M upon close. 
- Insurance recovery: Confident in court outcome but timeline uncertain. 
- Resource constraints: Balancing VLN growth with limited cash, prioritizing CMO profitability.

Actual								-335340	-447120	-335340	-558900	-335340	-335340	-670680	-1006020	-558900	-670680	-670680	-1341360	-894240	-1043280	-2742336	-856980	-80109	-13972.5	-12575.25	-3653.55	-652.05	-197.4	-15.9
Forecast									-447120	-447120	-335340	-335340	-335340	-447120	-614790	-633420	-603612	-648324	-689682.6	-824489.28	-798928.92	-685584	-414442.98	-245916	-231012	-223560	-223560	-379.5	-93.15	-251.85	-2.1
Surprise	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	+25.00%	-66.67%	0.00%	0.00%	-50.00%	-63.64%	+11.76%	-11.11%	-3.45%	-94.49%	-8.46%	-30.58%	-300.00%	-106.78%	+67.42%	+93.95%	+94.38%	+98.37%	-71.82%	-111.92%	+93.69%	0.00%

Actual	--	--	--	--	--	--	--	7.10M	6.40M	7.30M	7.30M	6.80M	8.40M	7.80M	8.00M	9.00M	14.50M	19.38M	19.21M	21.96M	23.43M	17.81M	7.36M	6.47M	7.95M	5.95M	4.02M	5.96M	4.08M	4.01M	--
Forecast	--	--	--	--	--	--	--	--	5.00M	5.50M	6.00M	--	7.10M	8.31M	10.07M	8.43M	11.74M	19.95M	19.37M	19.98M	24.01M	18.72M	17.11M	7.86M	8.21M	8.56M	8.91M	4.70M	5.44M	4.20M	4.05M
Surprise	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	+28.00%	+32.73%	+21.67%	0.00%	+18.31%	-6.14%	-20.52%	+6.80%	+23.52%	-2.83%	-0.84%	+9.93%	-2.43%	-4.87%	-56.99%	-17.67%	-3.17%	-30.51%	-54.87%	+26.72%	-24.94%	-4.50%	0.00%

XXII

XXII fundamentals

XXII Q4 2025 Earnings Preview

Earnings Call

You can ask Aime

XXII

XXII fundamentals

XXII Q4 2025 Earnings Preview

Earnings Call

XXII Earnings Call Summary for Q4/2025Today8:00 AM on Mar 26, 2026

XXII Earnings Call Summary for Q3/20258:00 AM on Nov 4, 2025

XXII Earnings Call Summary for Q2/20258:00 AM on Aug 14, 2025

XXII Earnings Call Summary for Q1/20258:00 AM on May 13, 2025

XXII Earnings Call Summary for Q4/2024Invalid Date on Mar 20, 2025

You can ask Aime